TY - JOUR
KW - Cardiovascular disease
KW - Cohort study
KW - drug utilization
KW - glucose-lowering medications
KW - pharmacoepidemiology
KW - Type 2 diabetes
AU - D. Abrahami
AU - E. D'Andrea
AU - H. Yin
AU - S. Kim
AU - J. Paik
AU - D. Wexler
AU - L. Azoulay
AU - E. Patorno
AD - Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada.
Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts, USA.
Massachusetts General Hospital Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.
Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada.
AN - 37395339
BT - Diabetes Obes Metab
DO - 10.1111/dom.15196
DP - NLM
ET - 2023/07/03
LA - eng
N1 - 1463-1326
Abrahami, Devin
D'Andrea, Elvira
Yin, Hui
Kim, Seoyoung C
Paik, Julie M
Wexler, Deborah
Azoulay, Laurent
Orcid: 0000-0001-5162-3556
Patorno, Elisabetta
Orcid: 0000-0002-8809-9898
K08AG055670/AG/NIA NIH HHS/United States
5U01FD007213/FD/FDA HHS/United States
Journal Article
England
Diabetes Obes Metab. 2023 Jul 3. doi: 10.1111/dom.15196.
PY - 2023
SN - 1462-8902
T2 - Diabetes Obes Metab
TI - Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom
ER -